The extent and outcome of lung involvement in cigarette smokers with Covid-19
International Academic Research Journal of Internal Medicine and Public Health · 08.09.2024 · 5 (2) · 1-12
DOI: 10.47310/iarjimph.2024.v05i02.08 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Academic Research Journal of Internal Medicine and Public Health, online erschienen am 08.09.2024. Verfasst von Israa Qabel Habeeb und 1 weiteren Autor:innen.
Abstract (Originalsprache)
Background
For example, the World Health Organization (WHO) is worried that smoking could make COVID-19 more common. Aim of Study: This study aimed to determine the extent of lung involvement and its outcomes in cigarette smokers with COVID-19 as evaluated by CT scan imaging in Kirkuk city. It is the first study of its kind conducted in Iraq. Patients and Methods: From December 1, 2020, to February 28, 2021, a prospective observational study was done in the city of Kirkuk. Six hundred people who were sick with COVID-19 and went to Kirkuk General Hospital, Al-Shifaa Epidemiological Hospital, or Azadi Teaching Hospital were part of the study. The COVID-19 diagnosis was based on WHO guidelines and was supported by RT-PCR testing of samples from the nose and throat. The clinical range of COVID-19 was categorized based on guidelines from the China Center for Disease Control and Prevention. Within 3–7 days of the infection, a chest CT scan was done to see how involved the lungs were and to find pneumonia. Two weeks after the infection, patients were called to see if their health had improved, gotten worse, or died.
Results
Of the 600 COVID-19 cases, 16.33% (98 of them) were smokers. For smokers, the chance of getting a serious COVID-19 infection went up with age and was higher for men. It was found that 42.86% of smokers had a serious infection, 10.2% had a critical infection, and 24.49% had a moderate infection (P<0.001). Most of the tobacco patients smoked less than 20 cigarettes a day, but 18.37% smoked more than 20 cigarettes a day. After two weeks, 73.47% of smoking patients got better, 20.41 % had problems, and 6.12 % had died. The patients who had died smoked 36.67 cigarettes a day on average, followed by those who had problems (19 cigarettes) and those who got better (12.75 cigarettes) (P<0.001). A positive relationship was found between the number of cigarettes smoked each day and CT results (r: 0.51, P<0.01) and the length of time someone smoked (r: 0.31, P<0.05). The longer someone smoked and their spO2 level were both negatively related (r: -0.78, P<0.001), as was the number of cigarettes they smoked each day (r: -0.75, P<0.001).
Conclusions
The chance of getting COVID-19 went up with age and male gender in users. A lot of the people who were there had been smoking for more than 11 years. The study found that the people who had died had smoked for an average of 29 years and smoked the most cigarettes every day. For smokers with COVID-19, there was a link between the length of time they had smoked and the results of the CT scan and a link between the length of time they had smoked and their spO2 level.
Zitieren
APA
Habeeb, I. Q., & Zangana, S. M. H. (2024). The extent and outcome of lung involvement in cigarette smokers with Covid-19. International Academic Research Journal of Internal Medicine and Public Health, 5(2), 1-12. https://doi.org/10.47310/iarjimph.2024.v05i02.08
Vancouver
Habeeb IQ, Zangana SMH. The extent and outcome of lung involvement in cigarette smokers with Covid-19. International Academic Research Journal of Internal Medicine and Public Health. 2024;5(2):1-12. doi:10.47310/iarjimph.2024.v05i02.08
BibTeX
@article{Habeeb2024,
author = {Habeeb, Israa Qabel and Zangana, Sabah Mohammed Hameed},
title = {The extent and outcome of lung involvement in cigarette smokers with Covid-19},
journal = {International Academic Research Journal of Internal Medicine and Public Health},
year = {2024},
volume = {5},
number = {2},
pages = {1--12},
doi = {10.47310/iarjimph.2024.v05i02.08}
}
EUVIMED